Source: Current Medicinal Chemistry. Unidade: FCFRP
Subjects: DOENÇAS PARASITÁRIAS, FÁRMACOS (EXPERIMENTOS)
ABNT
BERNARDES, Lílian Sibelle Campos e ZANI, Carlos Leomar e CARVALHO, Ivone. Trypanosomatidae diseases: from the current therapy to the efficacious role of trypanothione reductase in drug discovery. Current Medicinal Chemistry, v. 20, n. 21, p. 2673-2696, 2013Tradução . . Acesso em: 30 ago. 2024.APA
Bernardes, L. S. C., Zani, C. L., & Carvalho, I. (2013). Trypanosomatidae diseases: from the current therapy to the efficacious role of trypanothione reductase in drug discovery. Current Medicinal Chemistry, 20( 21), 2673-2696.NLM
Bernardes LSC, Zani CL, Carvalho I. Trypanosomatidae diseases: from the current therapy to the efficacious role of trypanothione reductase in drug discovery. Current Medicinal Chemistry. 2013 ; 20( 21): 2673-2696.[citado 2024 ago. 30 ]Vancouver
Bernardes LSC, Zani CL, Carvalho I. Trypanosomatidae diseases: from the current therapy to the efficacious role of trypanothione reductase in drug discovery. Current Medicinal Chemistry. 2013 ; 20( 21): 2673-2696.[citado 2024 ago. 30 ]